Skip to content
LIVE
Business·AstraZeneca $27B wipeout as Wainua late trial misses cardiovascular targetTechnology·OpenAI replaces Advanced Voice Mode with full-duplex GPT-Live, rolling out to all tiers todayBusiness·AstraZeneca $27B wipeout as Wainua late trial misses cardiovascular targetTechnology·OpenAI replaces Advanced Voice Mode with full-duplex GPT-Live, rolling out to all tiers today
The Executives BriefThe Executives BriefBeta

Loading the Newsroom

Curating from trusted global sources…